Anti-coagulant [EPC]

5893 reported adverse events

Drugs of this class: ASPIRIN, CITRIC ACID, SODIUM BICARBONATE BIVALIRUDIN ARGATROBAN ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE SODIUM CITRATE AND CITRIC ACID MONOHYDRATE ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) ADENOSINUM TRIPHOSPHORICUM DINATRUM, NADIDUM, ARGENTUM NITRICUM, IPECACUANHA, ROBINIA PSEUDOACACIA, SULPHUR, ORIGANUM VULGARE, DUODENUM (SUIS), ESOPHAGUS (SUIS), FUNICULUS UMBILICALIS SUIS, STOMACH (SUIS), NUX VOMICA, COUMARINUM, ERYTHRAEA CENTAURIUM, PANCREATINUM, MURIATICUM ACIDUM, CITRICUM ACIDUM, FORMICUM ACIDUM, SARCOLACTICUM ACIDUM, COENZYME A, PROTEUS (MORGANI) ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE

These side effects are most commonly reported by patients taking drugs of the Anti-coagulant [EPC] class:

# Side effect Count
0 CHRONIC KIDNEY DISEASE 730
1 ACUTE KIDNEY INJURY 474
2 RENAL FAILURE 471
3 DRUG INEFFECTIVE 420
4 OFF LABEL USE 291
5 THROMBOSIS IN DEVICE 291
6 HAEMORRHAGE 288
7 END STAGE RENAL DISEASE 260
8 THROMBOSIS 240
9 HEPARIN-INDUCED THROMBOCYTOPENIA 232
See all common reactions for Anti-coagulant [EPC]

Drugs of the Anti-coagulant [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION TIME ABNORMAL 128 0.5039
1 CORONARY ARTERY PERFORATION 29 0.2685
2 STENT OCCLUSION 97 0.1823
3 REPERFUSION INJURY 17 0.1466
4 CORONARY ARTERY THROMBOSIS 199 0.1092
5 CORONARY REVASCULARISATION 14 0.0986
6 THROMBOSIS IN DEVICE 291 0.0926
7 CARDIAC PROCEDURE COMPLICATION 43 0.0789
8 COAGULATION TIME PROLONGED 107 0.0779
9 COAGULATION TIME SHORTENED 18 0.0581
See all enriched reactions for Anti-coagulant [EPC]